Kevin De Bruyne to Undergo Medical at Wolfsburg Tomorrow – Reports

According to reports German tabloid Bild Chelsea’s midfielder, Kevin De Bruyne is expected to undergo a medical at Bundesliga club, Wolfsburg tomorrow, with both clubs agreeing a deal.

De Bruyne, has only made 6 starts for Chelsea since joining in January 2013, and is frustrated at not being able to secure his place in the team. He was the top scorer in the World Cup Qualifier for the Belgian national team; but has still not been able to tie down regular shirt for the Blues this season. In order to guarantee his place as Belgium prepares to go to the World Cup in Brazil this summer, there is needed to play regularly for us.

Chelsea are not short in the attacking third of the half, and can afford to do away with the services of the young Belgian international with Willian, Schurrle, Hazard, and Oscar as options.

Both Mourinho and Hazard have in recent times suggested that the player should consider a transfer option to a club where he can get regular playing time in order to further his career. With the German tabloid reporting that the deal is all but done, De Bruyne is now expected to move in the next few days to the Bundesliga. The fee is expected to be in the region of £20 Million, which will in turn be used to fund the transfer of Nemanja Matic back to Stanford Bridge. De Bruyne’s deal is expected to be for five and half years.

The news of De Bruyne’s move to Wolfsburg was also confirmed on twitter by former Middlesbrough player Jan Aage Fjortoft, who has called a number of transfers correctly including that of Arsenal’s Mesut Ozil last summer:

“Chelsea-player Kevin De Bruyne (22) has signed a 5,1/2 years deal with Wolfsburg. #cfc#bild You CAN do great deals in January!!!” Jan Aage Fjortoft tweeted.

The BBC’s Ben Smith also confirmed the transfer on his twitter account:

Kevin de Bruyne will join Wolfsburg in next 48 hours. Fee could rise to £20m. #CFC will use that money to re-sign Nemanja Matic.” Ben Smith said via his twitter page.


Comments are closed.